B-cell lymphoma
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
B-cell lymphoma
Jul 26, 2024, 08:01 |
Blog
July 2024 Tip Sheet of Sylvester Comprehensive Cancer Center
This month’s tip sheet from Sylvester Comprehensive Cancer Center at the University of Miami Miller…
Jul 21, 2024, 16:40 |
Insight
Hung Trinh: FDA breakthrough designation for trial of cell-based therapy for high-risk lymphoma
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Jul 16, 2024, 23:11 |
Blog
The role of TP53 and ctDNA kinetics in patients with R/R DLBCL
VJHemOnc (The Video Journal of Hematology and Hematological Oncology) shared a post on X: ''In…
Jul 12, 2024, 07:47 |
Blog
Potential breakthrough for patients with relapsed or refractory large B-cell lymphoma - Parker Institute for Cancer Immunotherapy
Yan Leyfman, Co-Founder and Executive Director at MedNews Week, shared a posted by Parker Institute…
Jun 27, 2024, 13:17 |
Insight
Non-chemotherapy treatment regimen for aggressive B-cell lymphoma
Kimryn Rathmell shared on X: "Exciting news: NCI researchers and collaborators have developed a non-chemotherapy…
Jun 23, 2024, 14:07 |
Blog
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Mark Roschewski, Senior Clinician in the Lymphoid Malignancies Branch at the National Cancer Institute, shared a…
Jun 11, 2024, 14:59 |
Insight
Timos Papagatsias: EHA24 is expected to be one of the most exciting EHA conferences to-date!
Timos Papagatsias, CEO of LucidQuest shared a post on LinkedIn: “EHA24 is fast approaching and…
May 24, 2024, 09:10 |
Stories
William Floyd High School Unites in Honor of Rayna’s Fight Against Cancer - St. Baldrick’s Foundation
St. Baldrick’s Foundation shared a post on LinkedIn: "Cara is a long-time volunteer who lost…
May 22, 2024, 06:44 |
Insight
Nausheen Ahmed: A deeper look at social determinants of health and CAR-T
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
Apr 21, 2024, 18:36 |
Blog
Talha Badar: Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity
Talha Badar, Assistant Professor of Oncology at Mayo Clinic, shared a post on X: “Real-World…
Apr 17, 2024, 11:47 |
Blog
The collaboration that ultimately led to a phase II clinical trial at Massachusetts General Hospital, where Serena found her miracle - St. Baldrick's Foundation
St. Baldrick's Foundation shared a post on LinkedIn: "David DiCillo (Dave) and Michael Tucker (Mike) are…
Feb 12, 2024, 01:17 |
Insight
Aaron Goodman: Sorting out High Grade B-cell Lymphomas using morphology and FISH!
Aaron Goodman shared a post on X/Twitter: “Sorting out High Grade B-cell Lymphomas using morphology and…
Jan 5, 2024, 11:32 |
Insight
Qiang Pan-Hammarström: We developed a new 24-gene expression score to identify high risk for developing refractory/relapsed lymphoma
Qiang Pan-Hammarström, Professor of Clinical Immunology and member of Nobel Assembly at the Karolinska Institute,…
Oct 12, 2023, 15:38 |
Insight
NCCN published the first Chemotherapy Order Templates for pediatric cancer. - National Comprehensive Cancer Network (NCCN)
National Comprehensive Cancer Network (NCCN) shared on LinkedIn: “NCCN published the first Chemotherapy Order Templates…
Sep 21, 2023, 18:12 |
Insight
Fiona Hamilton Marshall: These are hopeful findings for patients with relapsed/refractory diffuse large B-cell lymphomawho may not have a durable response to existing therapies.
Sep 20, 2023, 17:13 |
Insight
Jeff Ryckman: How many patients make it to CAR-T without ever seeing radiotherapy?
Jeff Ryckman, Radiation Oncologist and Assistant Professor at West Virginia University shared a post by…
Sep 14, 2023, 02:57 |
Insight
Michael Dickinson: In our article, we report on the development of rapid CART - YTB323, also known as rapcabtagene autoleucel.
Michael Dickinson, Haematologist at Peter MacCallum Cancer Centre, recently shared on LinkedIn: "RAPID CAR-T! Autologous…
All:
17
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube